Purchase Order 36C25025P0184

Award Date 12/5/24
Potential Completion Date 12/4/29
Potential Value $184K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dayton, OH 45428, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs, Network Contracting Office 10, awarded a firm-fixed-price Purchase Order to Biomerieux Inc., a global leader in in vitro diagnostics, for a Highly Specialized Hospital Equipment Service Agreement. The $363,012.75 contract provides diagnostic equipment, reagents, and maintenance services to support the Cincinnati VA Medical Center's microbiology testing operations over a multi-year period ending in March 2026. This sole-source award was not set aside and is...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a firm-fixed price purchase order to Biomerieux Inc. for Vitek Mass Spec and Myla Systems Maintenance and Support services. The contract has a total potential value of $153,826.20 and a completion date of December 4, 2024. This sole-source award was made under simplified acquisition procedures and was not set aside for any specific business category. Biomerieux Inc. is a foreign-owned, for-profit manufacturer that...
The U.S. Department of Veterans Affairs awarded a firm-fixed-price purchase order to Biomerieux Inc., a global in vitro diagnostics company, for a full service plan to maintain and support their MYLA, VITEK MS, BacT/ALERT 3D, and VITEK 2 laboratory equipment used by the Boise VA Medical Center. The $224,904 contract has a period of performance through May 5, 2027 and does not utilize any set-aside designations. This requirement was sole-sourced to Biomerieux as the original equipment...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract worth $29,559.00 to Biomerieux Inc. for automated blood culture testing equipment and supplies. The contract has a period of performance through June 3, 2025. Biomerieux Inc., a global leader in in vitro diagnostics, is providing its proprietary VITEK, BioFire, and VIDAS platforms and associated consumable products to support infectious disease testing and pathogen detection across VA healthcare...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order contract valued at $65,502.11 to Biomerieux Inc. for a Biomerieux micro-organism identification and susceptibility clinical laboratory testing system. The contract is to provide a VITEK 2 60 Clinical instrument and associated supplies to the VA Central California Health Care System's Pathology & Laboratory Medicine Service. This is a sole-source award under FAR 13.106-1(b) and 41 USC 1901, as the VA...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics, for a BIOMERIEUX VITEK AND MYLA SERVICE CONTRACT. The contract has a ceiling value of $138,404.00 and an ultimate completion date of May 31, 2027. This award is not associated with any set-aside designation. The contract primarily involves the supply of Biomerieux's proprietary diagnostic platforms, such as VITEK, BioFire, and VIDAS systems,...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics, for a Highly Specialized Hospital Equipment Service Agreement. The $101,940.00 contract is to provide the Dayton VA Medical Center with a VITEK 2 Analyzer system, associated reagents, and maintenance services over a 5-year period of performance. The contract was sole-sourced to Biomerieux as the provider of this proprietary diagnostic platform....
This firm-fixed-price delivery order was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of molecular pathogen detection solutions. The $307,432.70 contract has an ultimate completion date of January 12, 2026 and was awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the Department of Veterans Affairs. Biomerieux will supply its proprietary diagnostic platforms and consumables, such as the BioFire FilmArray system, VITEK...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of VIDAS immunoassay products for the Orlando VAMC laboratory. The contract has a period of performance ending on May 31, 2024, with a ceiling value of $49,190.40. Biomerieux Inc. holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and other agencies for its proprietary...
The U.S. Department of Veterans Affairs (VA) has awarded a Firm-Fixed-Price Blanket Purchase Agreement (BPA) Call to Biomerieux Inc., a global leader in in vitro diagnostics, with a ceiling value of $45,935.20. The contract is for DO LAB CPT AO ID SUSCEPTIBILITY - FARGO and does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. Division, will provide specialized diagnostic equipment, reagents, and services to support infectious disease testing and pathogen detection...

The U.S. Department of Veterans Affairs (VA), Network Contracting Office 10 in Cincinnati, Ohio, has awarded a sole-source, firm-fixed-price contract to Biomerieux Inc. for a Myla Service Agreement to support the Dayton VA Medical Center. The $184,403.16 contract, awarded on December 5, 2024, has a period of performance through December 4, 2029.

The contract provides for Biomerieux, a global leader in in vitro diagnostics, to supply specialized hospital services and products, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated consumables. This is a direct award to Biomerieux, without any set-aside designation, as the company is the sole source provider for the required technologies. The contract is funded by the VA and supports the agency's healthcare operations by enabling rapid and accurate pathogen detection and identification capabilities.

Generated 11/5/24, 9:17 AM